Molecule of pharmaceutical interest comprising at its N-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid.

摘要

The invention concerns a molecule of pharmaceutical interest, preferably a major histocompatibility complex (MHC) ligand, comprising a glutamic acid or a glutamine at its N-terminal, in the form of a physiologically acceptable addition salt, and a vaccine comprising such a ligand.